Isatuximab in Type I Cryoglobulinemia

Clinical trial NCT05114109 · UNKNOWN

Trial details

NCT number: NCT05114109
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Monoclonal Gammopathy of Undetermined Significance Cryoglobulinemic Vasculitis

Start date: 2021-11-01
Primary completion: 2022-12-31
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.